Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

416 trials

NCT05817903
Recruiting
Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients
Phase 2 · Spain, Italy · 45 sites
Registry update: 8 May 2023
NCT05856981
Recruiting
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Phase 1 · Belgium, Spain, United States · 11 sites
Registry update: 3 Nov 2026
2024-515109-24-00
Recruiting
Measuring Oncological Value of Exercise and Statin (MOVES)
Phase 3 · Finland · 1 site
Registry update: 21 May 2026
NCT05796973
Recruiting
Measuring Oncological Value of Exercise and Statin
Phase 3 · Finland · 1 site
Registry update: 27 Jun 2025
NCT06995664
Recruiting
Partial Volume High-Dose Irradiation in Renal Cell Carcinoma for Intra-TUmoural Control ALongside Current Management
Not applicable · United Kingdom · 1 site
Registry update: 29 May 2025
NCT05706129
Recruiting
A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
Phase 1/2 · Australia, Belgium, France · 13 sites
Registry update: 11 Aug 2026
NCT05184790
Recruiting
LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology
Not applicable · Australia · 4 sites
Registry update: 19 May 2026
NCT05765084
Recruiting
Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma
Phase 1/2 · Belgium · 3 sites
Registry update: 5 Jun 2026
NCT03669783
Recruiting
Clinical Trial for Patients With a Stage IV Childhood Renal Tumor, Comparing Upfront Vincristine, Actinomycin-D and Doxorubicin (Standard Arm) With Upfront Vincristine, Carboplatin and Etoposide (Experimental Arm)
Phase 3 · France · 1 site
Registry update: 8 Apr 2025
NCT05768464
Recruiting
Postoperative Adjuvant Therapy for Non-clear Renal Cell Carcinoma With High-risk Recurrence Factors
Phase 2 · China · 2 sites
Registry update: 14 Mar 2023
NCT05327686
Recruiting
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Phase 2 · Australia, Canada, Ireland, United States · 348 sites
Registry update: 23 Oct 2026
NCT05728957
Recruiting
Renal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for Patients With Clinically Localized Renal Tumors
Not applicable · United States · 1 site
Registry update: 19 Mar 2025
NCT05759923
Recruiting
First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Selected Advanced and/or Metastatic Solid Tumours
Phase 1 · Poland · 3 sites
Registry update: 31 Jul 2026
NCT05572216
Recruiting
A CCafU-UroCCR Randomized Trial: 3D Image-Guided Robot-AssisTEd Partial Nephrectomy for Renal Complex Tumor (UroCCR N°99)
Not applicable · France · 2 sites
Registry update: 18 Nov 2024
NCT05326620
Recruiting
National PROspective Infrastructure for Renal Cell Carcinoma (PRO-RCC)
Not applicable · Netherlands · 26 sites
Registry update: 6 Jun 2025
NCT05519878
Recruiting
Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
Not applicable · United States · 1 site
Registry update: 19 Oct 2026
NCT05319015
Recruiting
Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus
Phase 2 · United States · 1 site
Registry update: 16 Sept 2026
NCT06016075
Recruiting
Investigation of Differential Biology of Benign and Malignant Renal Masses Using Advanced Magnetic Resonance Imaging Techniques
Not applicable · United Kingdom · 1 site
Registry update: 5 Dec 2024
NCT05589207
Recruiting
Predicting Model Based on Evidence-based Pathological Diagnose Criteria for RCC Tumor Thrombus With IVC Wall Invasion
Not applicable · China · 1 site
Registry update: 21 Feb 2023
NCT05917106
Recruiting
Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)
Not applicable · China · 1 site
Registry update: 11 Dec 2025

Ordered by registry start date. Freshness and sponsorship never change the order.